Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 212

1.

External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.

Gay HA, Sanda MG, Liu J, Wu N, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal CS, Litwin MS, Kuban DA, Hembroff L, Regan MM, Chang P; Prostate Cancer Outcomes and Satisfaction with Treatment Quality Assessment Consortium, Michalski JM.

Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):304-317. doi: 10.1016/j.ijrobp.2017.02.019. Epub 2017 Feb 22.

2.

Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy.

Holliday EB, Kuban DA, Levy LB, Bolukbasi Y, Master P, Choi S, Nguyen Q, McGuire SE, Mahmood U, Frank SJ, Hoffman KE.

Prostate Cancer Prostatic Dis. 2017 May 2. doi: 10.1038/pcan.2017.24. [Epub ahead of print]

PMID:
28462945
3.

Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding.

Lee JY, Daignault-Newton S, Heath G, Scarlett S, Sanda MG, Chang P, Regan MM, Michalski JM, Sandler HM, Feng FY, Kuban DA, Zietman AL, Ciezki JP, Kaplan ID, Crociani C, McLaughlin WP, Mantz CA, Finkelstein SE, Suy S, Collins SP, Garin O, Ferrer M, Hamstra DA, Spratt DE.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):770-777. doi: 10.1016/j.ijrobp.2016.07.038. Epub 2016 Aug 3.

PMID:
27663760
4.

Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial.

Hoffman KE, Skinner H, Pugh TJ, Voong KR, Levy LB, Choi S, Frank SJ, Lee AK, Mahmood U, McGuire SE, Schlembach PJ, Du W, Johnson J, Kudchadker RJ, Kuban DA.

Am J Clin Oncol. 2016 Sep 15. [Epub ahead of print]

PMID:
27635624
5.

Qigong/tai chi for sleep and fatigue in prostate cancer patients undergoing radiotherapy: a randomized controlled trial.

McQuade JL, Prinsloo S, Chang DZ, Spelman A, Wei Q, Basen-Engquist K, Harrison C, Zhang Z, Kuban D, Lee A, Cohen L.

Psychooncology. 2016 Aug 22. doi: 10.1002/pon.4256. [Epub ahead of print]

PMID:
27548839
6.

Is "Active Surveillance" an Acceptable Alternative?: A Qualitative Study of Couples' Decision Making about Early-Stage, Localized Prostate Cancer.

Le YL, McFall SL, Byrd TL, Volk RJ, Cantor SB, Kuban DA, Mullen PD.

Narrat Inq Bioeth. 2016;6(1):51-61. doi: 10.1353/nib.2016.0006.

7.

Assessing the Quality of a Radiation Oncology Case-Based, Peer-Review Program in an Integrated Academic and Community Cancer Center Network.

Thaker NG, Sturdevant L, Jhingran A, Das P, Delclos ME, Gunn GB, McAleer MF, Tereffe W, Choi SL, Frank SJ, Simeone WJ Jr, Martinez W, Hahn SM, Famiglietti R, Kuban DA.

J Oncol Pract. 2016 Apr;12(4):e476-86. doi: 10.1200/JOP.2015.005983. Epub 2016 Mar 1.

PMID:
26931402
8.

Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.

Thaker NG, Pugh TJ, Mahmood U, Choi S, Spinks TE, Martin NE, Sio TT, Kudchadker RJ, Kaplan RS, Kuban DA, Swanson DA, Orio PF, Zelefsky MJ, Cox BW, Potters L, Buchholz TA, Feeley TW, Frank SJ.

Brachytherapy. 2016 May-Jun;15(3):274-82. doi: 10.1016/j.brachy.2016.01.003. Epub 2016 Feb 23.

PMID:
26916105
9.

Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy.

Evans JR, Zhao S, Daignault S, Sanda MG, Michalski J, Sandler HM, Kuban DA, Ciezki J, Kaplan ID, Zietman AL, Hembroff L, Feng FY, Suy S, Skolarus TA, McLaughlin PW, Wei JT, Dunn RL, Finkelstein SE, Mantz CA, Collins SP, Hamstra DA; PROSTQA Study Consortium.

Radiother Oncol. 2015 Aug;116(2):179-84. doi: 10.1016/j.radonc.2015.07.016. Epub 2015 Aug 11.

PMID:
26276528
10.

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.

Rosenthal SA, Hunt D, Sartor AO, Pienta KJ, Gomella L, Grignon D, Rajan R, Kerlin KJ, Jones CU, Dobelbower M, Shipley WU, Zeitzer K, Hamstra DA, Donavanik V, Rotman M, Hartford AC, Michalski J, Seider M, Kim H, Kuban DA, Moughan J, Sandler H.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):294-302. doi: 10.1016/j.ijrobp.2015.05.024. Epub 2015 Jul 21.

11.

Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance.

Davis JW, Ward JF 3rd, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim J.

BJU Int. 2016 Jul;118(1):68-76. doi: 10.1111/bju.13193. Epub 2015 Jul 4.

PMID:
26059275
12.

Assessing the Optimum Use of Androgen-Deprivation Therapy in High-Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy.

Ludwig MS, Kuban DA, Strom SS, Du XL, Lopez DS, Yamal JM.

Am J Mens Health. 2015 Apr 19. pii: 1557988315581396. [Epub ahead of print]

PMID:
25891393
13.

The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation.

Ludwig MS, Kuban DA, Strom SS, Du XL, Lopez DS, Yamal JM.

BMC Cancer. 2015 Mar 27;15:190. doi: 10.1186/s12885-015-1180-6.

14.

Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance.

Parker PA, Davis JW, Latini DM, Baum G, Wang X, Ward JF, Kuban D, Frank SJ, Lee AK, Logothetis CJ, Kim J.

BJU Int. 2016 Mar;117(3):469-77. doi: 10.1111/bju.13099. Epub 2015 Apr 21.

15.

Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form.

Skolarus TA, Dunn RL, Sanda MG, Chang P, Greenfield TK, Litwin MS, Wei JT; PROSTQA Consortium.

Urology. 2015 Jan;85(1):101-5. doi: 10.1016/j.urology.2014.08.044.

16.

Local recurrence map to guide target volume delineation after radical prostatectomy.

Wang J, Kudchadker R, Choi S, Pettaway CA, Choi H, Hobbs BD, Occena MC, McGuire SE, Pugh TJ, Hoffman K, Mahmood U, Kuban DA.

Pract Radiat Oncol. 2014 Nov-Dec;4(6):e239-46. doi: 10.1016/j.prro.2014.02.007. Epub 2014 Apr 16.

PMID:
25407875
17.

Prospective peer review quality assurance for outpatient radiation therapy.

Ballo MT, Chronowski GM, Schlembach PJ, Bloom ES, Arzu IY, Kuban DA.

Pract Radiat Oncol. 2014 Sep-Oct;4(5):279-84. doi: 10.1016/j.prro.2013.11.004. Epub 2013 Dec 18. Review.

PMID:
25194094
18.

Establishing high-quality prostate brachytherapy using a phantom simulator training program.

Thaker NG, Kudchadker RJ, Swanson DA, Albert JM, Mahmood U, Pugh TJ, Boehling NS, Bruno TL, Prestidge BR, Crook JM, Cox BW, Potters L, Moran BJ, Keyes M, Kuban DA, Frank SJ.

Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):579-86. doi: 10.1016/j.ijrobp.2014.06.036. Epub 2014 Aug 20.

PMID:
25151539
19.

Physician variation in management of low-risk prostate cancer: a population-based cohort study.

Hoffman KE, Niu J, Shen Y, Jiang J, Davis JW, Kim J, Kuban DA, Perkins GH, Shah JB, Smith GL, Volk RJ, Buchholz TA, Giordano SH, Smith BD.

JAMA Intern Med. 2014 Sep;174(9):1450-9. doi: 10.1001/jamainternmed.2014.3021.

20.

Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic.

Madsen LT, Kuban DA, Choi S, Davis JW, Kim J, Lee AK, Domain D, Levy L, Pisters LL, Pettaway CA, Ward JF, Logothetis C, Hoffman KE.

J Natl Compr Canc Netw. 2014 Jul;12(7):993-8.

Supplemental Content

Loading ...
Support Center